English
Procter & Gamble Health Q2 Results
- BSE: 500126
- NSE: PGHL
- ISIN: INE199A01012
- Sector: Biotechnology & Drugs
BSE
5,930.00
-8.20 (-0.14%)
-8.20 (-0.14%)Volume155.00
Updated: Tue 11 Nov, 2025 | 15:28:32
NSE
5,908.50-32.50 (-0.55%)
-32.50 (-0.55%)Volume4.91 K
Updated: Tue 11 Nov, 2025 | 15:29:57
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹324.92 Cr.(3.67%)
- Operating Profit₹114.19 Cr.(5.47%)
- Profit After Tax₹88.54 Cr.(7.54%)
- Operating Margin35.14%(377.35%)
Note: Comparison is on YoY basis
Quarterly - Procter & Gamble Health Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 210.73 | 205.14 | N/A | 215.24 | 2.72% |
| Depreciation/ Amortization | 6.08 | 5.77 | N/A | 6.92 | 5.37% |
| Operating Income | 114.19 | 108.27 | N/A | 94.73 | 5.47% |
| Net Income | 88.54 | 82.33 | N/A | 72.07 | 7.54% |
| Other Operating Expenses Total | 82.37 | 65.10 | N/A | 60.50 | 26.53% |
| Net Income Before Taxes | 119.02 | 111.40 | N/A | 99.72 | 6.84% |
| Total Revenue | 324.92 | 313.41 | N/A | 309.97 | 3.67% |
| Selling/ General/ Admin Expenses Total | 53.88 | 46.22 | N/A | 57.43 | 16.57% |
| Diluted Normalized EPS | 53.34 | 49.60 | N/A | 43.40 | 7.54% |